Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 155   

Articles published

MRK 59.46 +0.49 (0.83%)
price chart
Merck & Co. Inc. (MRK) Closes 0.69% Down on the Day for May 26
Dow Jones component Merck & Co. Inc. (MRK) saw its stock move -0.69% to $58.97, representing a per-share move of $0.41, on volume of 10.8 million shares for Tuesday.
Healthcare Most Active Stocks: Merck & Co. Inc. (NYSE:MRK), Pfizer Inc. (NYSE ...
Merck & Co. Inc. (NYSE:MRK) slightly down in last trading session as MSD, known as Merck & Co., Inc. in the U.S.
Merck & Co. (MRK) - Analysts' Recent Ratings Updates  Mideast Time
Morning Investor Watch: Zynga, Inc. (ZNGA), Merck & Co. Inc. (MRK ...  WallStreet Scope
Active Runners- Mentor Graphics Corp. (NASDAQ:MENT), Merck & Co. Inc ...
Merck & Co. Inc. (NYSE:MRK) reported that a positive opinion from the Committee for Medicinal Products for Human Use or CHMP for its advanced skin cancer therapy Keytruda or pembrolizumab in patients by means of unresectable or metastatic melanoma.
Investor Alerts- Cerulean Pharma Inc. (NASDAQ:CERU), Merck & Co. Inc. (NYSE ...
Cerulean Pharma Inc. (NASDAQ:CERU) [Trend Analysis] declared that the U.S. Food and Drug Administration has decided orphan drug designation to CRLX101 for the treatment of ovarian cancer.
Merck & Co Inc (NYSE:MRK) close to 52-week high, short interest decreasing
Merck & Co Inc (NYSE:MRK) (TREND ANALYSIS) shares were traded with thin volume. The stock closed last trading session at $60.1, down by -0.6%, with a volume of 8,039,016 shares against an average volume for the last 3 months of 11,301,000.
Analyst Watch: Merck & Company, Inc. (NYSE:MRK)  Markets Daily
Jefferies Group Raises Merck & Co. Price Target to $66.00 (MRK)  Mideast Time
Earnings Buzz: Pfizer Inc (PFE), Merck & Co Inc (MRK), Bristol-Myers Squibb Co ...
Pfizer Inc. (NYSE:PFE) shares edged up 0.5 percent Tuesday, despite cutting its full-year 2015 earnings forecast due to a stronger U.S.
Whisper Numbers: Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), And Bristol ...  Bidness ETC
Pfizer, Merck and Bristol-Myers Squibb Report Solid Results  Wall Street Journal
Merck & Co., Inc. (NYSE:MRK)'s EVP & Pres-Global Human Health Adam ...
Two days ago, an insider trading deal was made. Adam Schechter, the EVP & Pres-Global Human Health and an insider of Merck & Co., Inc. (NYSE:MRK) 58.97 -0.41 -0.69% sold a total of 10,634 shares of Merck & Co. Inc, worth close to $642,768 USD, ...
Deutsche Bank Reaffirms Hold Rating for Merck & Co. (MRK)  Dakota Financial News
Merck & Co. Given Consensus Recommendation of "Hold" by ...  sleekmoney
Analytic Report on Merck & Co Inc (NYSE:MRK)
[Business Wire] Merck & Co Inc (NYSE:MRK)(TREND ANALYSIS) known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2015.
Merck & Co. Assigned AA Credit Rating (MRK)  Dakota Financial News
Large Cap Stocks to Keep Your Eyes on- Merck (MRK), Bank of America (BAC ...  Techsonian (press release)
Merck & Co., Inc. Raises 2015 Outlook; Q1 Results Beat Estimates On Growth ...
Before the market opened today, pharmaceutical giant Merck & Co., Inc. (NYSE:MRK) announced first-quarter results for fiscal'15, reporting higher-than-expected growth in earnings and revenues, primarily due to increasing sales of its newer drugs.
PeptiDream Announces Peptide Discovery Collaboration Agreement with Merck ...
Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform System (PDPS) technology to generate macrocylic/constrained peptides against multiple targets of interest selected by Merck & Co. Inc. Merck & Co. Inc. will have the ...